The remarkable decrease of IFN-γ–producing CD4+ and CD8+ T cells was observed in the lungs of E0771 tumor–bearing mice that received GEM treatment (Supplemental Figure 1; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.167499DS1). This evidence concerns the gene CD8A and neoplasm.